Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06288763 · ClinicalTrials.gov registry record
Nerve Transfer to Improve Function in High Level Tetraplegia
A clinical trial of Tetraplegia and Cervical Spinal Cord Injury, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 30
- Enrollment target
- 10
- Study locations
NCT06288763: Recruiting study of Tetraplegia and Cervical Spinal Cord Injury, sponsored by Washington University School of Medicine.
NCT06288763 is a study of Tetraplegia and Cervical Spinal Cord Injury that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 30 participants, above the 18-participant average among 23 other Tetraplegia trials with a reported enrollment target (67% higher). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06288763, a study of Tetraplegia and Cervical Spinal Cord Injury, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this observational study is to determine if nerve transfer surgeries improve upper extremity function and quality of life in patients with a high level cervical spinal cord injury. Participants will: * undergo standard of care pre- and post-op testing and study exams * complete pre- and post-questionnaires * undergo standard of care nerve transfer surgeries * follow-up with surgeon at 6/12/18/24/36 and potentially at 48 months * attend therapy at local therapist for up to 2 years postop.
Primary Outcome
Change from baseline to 36-48 months post-surgery. Elbow dynamometer measures muscle strength using a handheld portable dynamometer
Conditions Studied
Study Locations (10)
California
- Stanford University - Stanford
Florida
- University of Miami - Miami
Maryland
- Johns Hopkins University - Baltimore
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University in St. Louis - St Louis
North Carolina
- Wake Forest Medical Center - Winston-Salem
Pennsylvania
- University of Pennsylvania - Philadelphia
Texas
- Houston Methodist - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2028-12-31 |
What NCT06288763 shows while recruiting
NCT06288763 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, above the 18-participant average among 23 other Tetraplegia trials with a reported enrollment target (67% higher).
The record links to 2 conditions, with Tetraplegia appearing as the primary indexed condition, and to 0 interventions.
NCT06288763 lists 10 locations in 10 states (California, Florida, Maryland).
Frequently Asked Questions
What is clinical trial NCT06288763 about?
NCT06288763 is a clinical study titled "Nerve Transfer to Improve Function in High Level Tetraplegia". The goal of this observational study is to determine if nerve transfer surgeries improve upper extremity function and quality of life in patients with a high level cervical spinal cord injury. Participants will: * undergo standard of care pre- and post-op testing and study exams * complete pre- an...
What is the current status of trial NCT06288763?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2024-02-05. Estimated completion is 2028-12-31.
What conditions does trial NCT06288763 study?
This clinical trial studies the following conditions: Tetraplegia, Cervical Spinal Cord Injury.
Who is sponsoring clinical trial NCT06288763?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06288763 being conducted?
This trial has 10 study locations across California, Florida, Maryland, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetraplegia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06288763's enrollment target sits among peer trials
30 4th of 23 higher than 17 of 23 other Tetraplegia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tetraplegia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Evaluation of an Advanced Lower Extremity Neuroprostheses
RECRUITING · NA
-
Nerve Transfers Plus Electrical Stimulation to Improve Hand Function in Cervical Spinal Cord Injury
RECRUITING
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
-
Investigation on the Cortical Communication (CortiCom) System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI